January 10, 2017 by Contributor in Neurology

No Evidence Prevagen Improves Memory: Government Lawsuit

Latest Neurology News There’s no scientific evidence to support claims that the dietary supplement Prevagen improves memory, a government lawsuit says. The lawsuit was filed Monday by the New York Attorney General and the Federal Trade Commission against Prevagen maker Quincy Bioscience. It seeks a ban on further claims about

Read More →
January 09, 2017 by Contributor in Neurology

Study Links Stuttering to Less Blood Flow in Brain

Latest Neurology News FRIDAY, Jan. 6, 2017 (HealthDay News) — Reduced blood flow in a part of the brain that’s linked to speech may put people at risk for stuttering, a small study suggests. There are also signs that the lower the blood flow in regions of the brain tied

Read More →
January 09, 2017 by Contributor in Neurology

Hour-Long Nap May Boost Brain Function in Older Adults

Latest Neurology News FRIDAY, Jan. 6, 2017 (HealthDay News) — Napping for an hour in the afternoon may provide a mental boost for older adults, a new study suggests. This extra daytime sleep was linked to improved memory and ability to think clearly among the Chinese study participants, the researchers

Read More →
January 06, 2017 by Contributor in Neurology

Want a Sharper Brain as You Age? Volunteer!

By Amy NortonHealthDay Reporter Latest Neurology News THURSDAY, Jan. 5, 2017 (HealthDay News) — People who are active in local community groups may have slightly sharper mental skills at the age of 50, a new study suggests. British researchers said their findings build on evidence that social engagement may help

Read More →
January 05, 2017 by Contributor in Neurology

Avonex (interferon beta 1a injection)

What is Avonex (interferon beta-1a), and how does it work? Interferon beta-1a (Avonex) is a protein produced by recombinant DNA technology using genetically engineered Chinese hamster ovary (CHO) cells into which the human interferon beta genes have been introduced. It is used for treating multiple sclerosis (MS). Interferon beta-1a is

Read More →
January 04, 2017 by Contributor in Neurology

New Parkinson’s Drug May Combat Movement Difficulties

By Alan MozesHealthDay Reporter Latest Neurology News TUESDAY, Jan. 3, 2017 (HealthDay News) — New research suggests that people with Parkinson’s disease may achieve better and more reliable motor control by taking an experimental drug called opicapone alongside the standard medication levodopa. A study of several hundred Parkinson’s patients found

Read More →